ATC代碼 (N02)
外觀
ATC |
---|
N 神經系統 |
N01 麻醉劑(Anesthetics) |
N02 止痛藥(Analgesics) |
N03 抗癲癇藥(Antiepileptics) |
N04 抗帕金森氏藥(Anti-parkinson drugs) |
N05 精神抑制藥(Psycholeptics) |
N06 精神興奮藥(Psychoanaleptics) |
N07 其他神經系統藥品(Other nervous system drugs) |
ATCvet專用 |
QN51 動物安樂死用品(Products for animal euthanasia) |
|
ATC代碼N02(鎮痛藥)是解剖學治療學及化學分類系統的一個藥物分組,這是由世界衛生組織藥物統計方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的藥品及其它醫用產品的官方分類系統。分組N02是N神經系統的一部分。[1]
獸用代碼(ATCvet碼)可以在人用ATC代碼前加Q字母:QN02等[2]。沒有相應人用ATC代碼的ATCvet在以下列表中通過前置Q字母表示。
國家ATC分類可能包括列表中沒有的其它分類,列表為世界衛生組織(WHO)版本。
- N02AA01 嗎啡(Morphine)
- N02AA02 阿片(Opium)
- N02AA03 二氫嗎啡酮(Hydromorphone)
- N02AA04 尼可嗎啡(Nicomorphine)
- N02AA05 羥考酮(Oxycodone)
- N02AA08 雙氫可待因(Dihydrocodeine)
- N02AA09 二醋嗎啡(Diamorphine)
- N02AA10 阿片全鹼(Papaveretum)
- N02AA51 嗎啡,複方(Morphine, combinations)
- N02AA55 羥考酮,複方(Oxycodone, combinations)
- N02AA58 雙氫可待因,複方(Dihydrocodeine, combinations)
- N02AA59 可待因,與非精神阻斷劑的複方(Codeine, combinations excluding psycholeptics)
- N02AA79 可待因,與精神阻斷劑的複方(Codeine, combinations with psycholeptics)
- N02AB01 凱托米酮(Ketobemidone)
- N02AB02 哌替啶(Pethidine)
- N02AB03 芬太尼(Fentanyl)
- N02AB52 哌替啶,與非安定藥的複方(Pethidine, combinations excluding psycholeptics)
- QN02AB53 芬太尼,與非安定藥的複方(Fentanyl, combinations excluding psycholeptics)
- N02AB72 哌替啶,與安定藥的複方(Pethidine, combinations with psycholeptics)
- N02AB60 哌替啶,混合(Pethidine, mixed)
- QN02AB73 芬太尼,與安定藥的複方(Fentanyl, combinations with psycholeptics)
- N02AC01 右嗎拉胺(Dextromoramide)
- N02AC03 哌腈米特(Piritramide)
- N02AC04 右丙氧芬(Dextropropoxyphene)
- N02AC05 貝齊米特(Bezitramide)
- N02AC52 美沙酮,與非安定藥的複方(Methadone, combinations excluding psycholeptics)
- N02AC54 右丙氧芬,與非安定藥的複方(Dextropropoxyphene, combinations excluding psycholeptics)
- N02AC74 右丙氧芬,與安定藥的複方(Dextropropoxyphene, combinations with psycholeptics)
- N02AE01 丁丙諾啡(Buprenorphine)
- QN02AE90 埃托啡(Etorphine)
- QN02AE99 東罌粟鹼衍生物,複方(Oripavine derivatives, combinations)
- N02AG01 嗎啡和解痙藥(Morphine and antispasmodics)
- N02AG02 凱托米酮和解痙藥(Ketobemidone and antispasmodics)
- N02AG03 哌替啶和解痙藥(Pethidine and antispasmodics)
- N02AG04二氫嗎啡酮和解痙藥(Hydromorphone and antispasmodics)
N02AX 其它生物鹼類(Other opioids)
[編輯]- N02AX01 替利定(Tilidine)
- N02AX02 曲馬多(Tramadol)
- N02AX03 地佐辛(Dezocine)
- N02AX05 美普他酚(Meptazinol)
- N02AX06 他噴他多(Tapentadol)
- N02AX52 曲馬多,複方(Tramadol, combinations)
- N02BA01 乙酰水楊酸(Acetylsalicylic acid)
- N02BA02 阿洛普令(Aloxiprin)
- N02BA03 水楊酸膽鹼(Choline salicylate)
- N02BA04 水楊酸鈉(Sodium salicylate)
- N02BA05 水楊酰胺(Salicylamide)
- N02BA06 雙水楊酯(Salsalate)
- N02BA07 乙水楊胺(Ethenzamide)
- N02BA08 水楊嗎啉(Morpholine salicylate)
- N02BA09 地匹乙酯(Dipyrocetyl)
- N02BA10 貝諾酯(Benorilate)
- N02BA11 二氟尼柳(Diflunisal)
- N02BA12 水楊酸鉀(Potassium salicylate)
- N02BA14 呱西替柳(Guacetisal)
- N02BA15 卡巴匹林鈣(Carbasalate calcium)
- N02BA16 水楊酸咪唑(Imidazole salicylate)
- N02BA51 乙酰水楊酸,與非安定藥的複方(Acetylsalicylic acid, combinations excluding psycholeptics)
- N02BA55 水楊酰胺,與非安定藥的複方(Salicylamide, combinations excluding psycholeptics)
- N02BA57 乙水楊胺,與非安定藥的複方(Ethenzamide, combinations excluding psycholeptics)
- N02BA59 地匹乙酯,與非安定藥的複方(Dipyrocetyl, combinations excluding psycholeptics)
- N02BA65 卡巴匹林鈣,與非安定藥的複方(Carbasalate calcium combinations excluding psycholeptics)
- N02BA71 乙酰水楊酸,與安定藥的複方(Acetylsalicylic acid, combinations with psycholeptics)
- N02BA75 水楊酰胺,與安定藥的複方(Salicylamide, combinations with psycholeptics)
- N02BA77 乙水楊胺,與安定藥的複方(Ethenzamide, combinations with psycholeptics)
- N02BA79 地匹乙酯,與安定藥的複方(Dipyrocetyl, combinations with psycholeptics)
- N02BB01 安替比林(Phenazone)
- N02BB02 安乃近(Metamizole)
- N02BB03 氨基比林(Aminophenazone)
- N02BB04 異丙安替比林(Propyphenazone)
- N02BB05 尼芬那宗(Nifenazone)
- N02BB51 安替比林,與非安定藥的複方(Phenazone, combinations excluding psycholeptics)
- N02BB52 安乃近,與非安定藥的複方(Metamizole sodium, combinations excluding psycholeptics)
- N02BB53 氨基比林,與非安定藥的複方(Aminophenazone, combinations excluding psycholeptics)
- N02BB54 異丙安替比林,與非安定藥的複方(Propyphenazone, combinations excluding psycholeptics)
- N02BB71 安替比林,與安定藥的複方(Phenazone, combinations with psycholeptics)
- N02BB72 安乃近,與安定藥的複方(Metamizole sodium, combinations with psycholeptics)
- N02BB73 氨基比林,與安定藥的複方(Aminophenazone, combinations with psycholeptics)
- N02BB74 異丙安替比林,與安定藥的複方(Propyphenazone, combinations with psycholeptics)
- N02BE01 對乙酰氨基酚(Paracetamol)
- N02BE03 非那西汀(Phenacetin)
- N02BE04 布西汀(Bucetin)
- N02BE05 丙帕他莫(Propacetamol)
- N02BE51 對乙酰氨基酚,與非安定藥的複方(Paracetamol, combinations excluding psycholeptics)
- N02BE53 非那西汀,與非安定藥的複方(Phenacetin, combinations excluding psycholeptics)
- N02BE54 布西汀,與非安定藥的複方(Bucetin, combinations excluding psycholeptics)
- N02BE71 對乙酰氨基酚,與安定藥的複方(Paracetamol, combinations with psycholeptics)
- N02BE73 非那西汀,與安定藥的複方(Phenacetin, combinations with psycholeptics)
- N02BE74 布西汀,與安定藥的複方(Bucetin, combinations with psycholeptics)
N02BG 其它解熱鎮痛藥(Other analgesics and antipyretics)
[編輯]- N02BG02 利馬唑(Rimazolium)
- N02BG03 格拉非寧(Glafenine)
- N02BG04 夫洛非寧(Floctafenine)
- N02BG05 維米醇(Viminol)
- N02BG06 奈福泮(Nefopam)
- N02BG07 氟吡汀(Flupirtine)
- N02BG08 齊考諾肽(Ziconotide)
- N02BG09 甲氧氟烷(Menthol)
- N02BG10 Nabiximols
N02CA 麥角生物鹼類(Ergot alkaloids)
[編輯]- N02CA01 雙氫麥角胺(Dihydroergotamine)
- N02CA02 麥角胺(Ergotamine)
- N02CA04 美西麥角(Methysergide)
- N02CA07 麥角乙脲(Lisuride)
- N02CA51 雙氫麥角胺,複方(Dihydroergotamine, combinations)
- N02CA52 麥角胺,與非安定藥的複方(Ergotamine, combinations excluding psycholeptics)
- N02CA72 麥角胺,與安定藥的複方(Ergotamine, combinations with psycholeptics)
N02CB 皮質甾體激素衍生物類(Corticosteroid derivatives)
[編輯]- N02CB01 氟美烯酮(Flumedroxone)
N02CC 選擇性5-羥色胺(5HT1)促效藥(Selective serotonin (5-HT1) agonists)
[編輯]- N02CC01 舒馬曲坦(Sumatriptan)
- N02CC02 那拉曲坦(Naratriptan)
- N02CC03 佐米曲坦(Zolmitriptan)
- N02CC04 利扎曲坦(Rizatriptan)
- N02CC05 阿莫曲坦(Almotriptan)
- N02CC06 依利曲坦(Eletriptan)
- N02CC07 氟羅曲坦(Frovatriptan)
N02CX 其它抗偏頭痛藥(Other antimigraine preparations)
[編輯]- N02CX01 苯噻啶(Pizotifen)
- N02CX02 可樂定(Clonidine)
- N02CX03 異丙佐羅(Iprazochrome)
- N02CX05 二甲替嗪(Dimetotiazine)
- N02CX06 奧昔托隆(Oxetorone)
參考文獻
[編輯]- ^ ATC Index. WHO Collaborating Centre for Drug Statistics Methodology.
- ^ ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.
|
|